Relief of Chronic Pain Act of 2025 has not moved since its introduction on Oct 28, 2025, with cosponsors split almost evenly between the parties

Relief of Chronic Pain Act of 2025 This bill reduces cost-sharing and prohibits the imposition of certain utilization requirements under the Medicare prescription drug benefit for certain non-opioid drugs for chronic pain management. Specifically, the bill requires such drugs to be covered without a deductible and to be placed on the lowest cost-sharing tier (if any). The bill also prohibits the imposition of prior authorization requirements (i.e., requiring prior approval from a plan) or step therapy requirements (i.e., requiring the use of alternative drugs before a drug is covered under a plan) with respect to such drugs.